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Allopregnanolone, a progesterone metabolite, is one of the best characterized 5 
neurosteroids. In a dose that mimics serum levels during stress, allopregnanolone inhibits 6 
sexual receptivity and ovulation and induces a decrease in luteinizing hormone levels. The 7 
aim of this work was to examine the effect of an intracerebroventricular administration of 8 
allopregnanolone on ovarian morphophysiology, serum and tissue levels of progesterone 9 
and estrogen, and enzymatic activity of 3β-hydroxysteroid dehydrogenase, 20α-10 
hydroxysteroid dehydrogenase and 3α–hydroxysteroid oxido-reductase in the ovary and in 11 
the medial basal hypothalamus on the morning of estrus. Ovarian morphology was 12 
analyzed under light microscopy. The hormone assays were performed by 13 
radioimmunoassay. The enzymatic activities were measured by spectrophotometric 14 
analysis. The morphometric analysis revealed that, in allopregnanolone-treated animals, 15 
the number of secondary and Graafian follicles was decreased while that of atretic follicles 16 
and cysts was significantly increased. Some cysts showed luteinized unruptured follicles. 17 
There were no differences in the number of tertiary follicles or corpora lutea in comparison 18 
with the corresponding control groups. In allopregnanolone-treated animals, progesterone 19 
serum levels were increased, while ovarian progesterone levels were decreased. Moreover, 20 
3β-HSD and 3α-HSOR enzymatic activities were increased in the medial basal 21 
hypothalamus while ovarian levels were decreased. The enzyme 20α-hydroxysteroid 22 
dehydrogenase showed the opposite profile. The results of this study showed that 23 
allopregnanolone interferes on ovarian steroidogenesis and ovarian morphophysiology in 24 
rats, providing a clear evidence for the role of this neurosteroid in the control of 25 
reproductive function under stress situations. 26 





Steroids are synthesized by the brain de novo from cholesterol or from an in situ 30 
metabolism of peripheral hormone precursors. As a whole, these steroids are known as 31 
“neurosteroids” (Baulieu 1997, Robel & Baulieu 1994, Melcangi & Panzica 2006, 2011). 32 
Neurosteroids are synthesized, stored and released in the central nervous system (CNS) 33 
and in the peripheral nervous system independently of classical steroidogenic glands, such 34 
as gonads and adrenals (Robel & Baulieu 1985, Corpéchot et al. 1993, Baulieu 1997, 35 
Melcangi & Panzica 2006). These neurosteroids include pregnenolone, progesterone (Pg) 36 
and allopregnanolone (ALLO). In particular, ALLO, also called 3α-hydroxy-5α-pregnan-37 
20-one or 3α-5α-tetrahydroprogesterone, is a metabolite of Pg (Majewska et al. 1986), and 38 
is synthesized in astrocytes (Micevych et al. 2003) and oligodendrocytes (Mensah –39 
Nyagan et al. 1999). ALLO synthesis implies the conversion of Pg to pregnenolone by 3β-40 
hydroxysteroid dehydrogenase (3β-HSD) and the reduction of this steroid by 3α–41 
hydroxysteroid oxido-reductase (3α-HSOR) (Patte-Mensah et al. 2010). Pg can also be 42 
metabolized by 20α-hydroxysteroid dehydrogenase (20α-HSD) (Clementi et al 2004). 43 
These enzymes are present in different regions, including the hypothalamus (Guennoun et 44 
al. 1995, Vidal et al. 2000) and the ovary (Vega Orozco et al. 2012). Micevych & Sinchak 45 
(2008) mentioned that neurosteroids are not isolated from peripheral steroid sources. 46 
Mutual interactions modulate their levels in the brain and periphery. Moreover, to provide 47 
a reservoir of steroids, circulating hormonal steroids modulate the site-specific synthesis of 48 
neurosteroids and their cognate receptors. This dual regulation of neurosteroidogenesis and 49 
post-synaptic receptor expression has profound implications for neurosteroid function. 50 
Interactions of peripheral steroids with neurosteroid synthesis are involved in regulating 51 
reproduction in the hypothalamus. The contribution from the brain to the pool of ALLO 52 
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measured in serum is minimal (in the order of nM), whereas the peripheral contribution of 53 
the sum of adrenal and ovarian production is in the order of µM (Purdy et al., 1990 and 54 
1991; Micevych & Sinchak 2008). 55 
ALLO is a positive allosteric modulator of the GABAA receptor and its effects are similar 56 
to those of benzodiazepines, and include sedative and anticonvulsant activities (Kokate et 57 
al. 1999, Laconi et al. 2001). Its action on the GABAA receptor is related to its neuro-58 
protective, neuro-modulatory and anti-gonadotropic properties (Concas et al. 1996; Purdy 59 
et al. 1991). The potency of ALLO in increasing GABA-activated Cl- currents is 60 
comparable to high-potency benzodiazepine. As in Cl
-
 flux studies (Morrow et al. 1987), 61 
low nanomolar concentrations of ALLO increase GABA-activated Cl- currents, whereas 62 
higher concentrations, in the low micromolar range, directly activate a bicuculline-63 
sensitive Cl- current.  64 
The affinity of ALLO for GABAA receptors is comparable to that of benzodiazepines and 65 
ALLO is one of the most potent GABAA receptor ligands. ALLO actions are mediated by 66 
synaptic and extra-synaptic receptors. ALLO interacts with synaptic GABAA receptors to 67 
produce phasic inhibition via specific bindings (Paul & Purdy 1992). 68 
Pg and ALLO have been studied in clinical trials of psychiatric disorders such as 69 
depression, anxiety, premenstrual irritability and menopausal syndrome as well as in 70 
neurodegenerative diseases such as Parkinson or Alzheimer and post-traumatic neuronal 71 
repair (Bicíková & Hampl, 2007).  72 
Previously, we reported that ALLO increases GnRH release through the glutamatergic 73 
system and NMDA receptors (Giuliani et al. 2011). Other authors reported that ALLO, in 74 
different strains of GT1 neurons, might either stimulate or have no effect on the release of 75 
GnRH (Sleiter et al 2009). Moreover, we have reported that i.c.v administration of ALLO 76 
induces an increase in endogenous dopamine concentration with a decrease in the 77 
dopamine/dopac turnover rate in the medial basal hypothalamus (MBH), indicating an 78 
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increase in dopamine metabolism. This action is mediated by the GABAA receptor (Laconi 79 
& Cabrera 2002). In addition, ALLO is able to reduce LH serum levels and anxiety levels 80 
and to inhibit lordosis in female rats (Laconi et al. 2001, Laconi & Cabrera 2002, Pelegrina 81 
et al. 2015). Moreover, Sleiter et al. (2009) found that Pg inhibits GnRH release through an 82 
action on membrane Pg receptors, but more evidence is needed to clarify the role of ALLO 83 
in GnRH release (Giuliani et al. 2011). Circulating levels of ALLO are usually according 84 
with Pg levels but stress or pathological situations could alter both ALLO and Pg levels 85 
(Purdy et al. 1991; Genazzani 1995). Stress is one of the main factors that alter ALLO 86 
circulating levels (Purdy et al. 1991), which could alter the reproductive axis. Bäckström et 87 
al. (2011) have shown that neurosteroid concentrations are variable, especially those acting 88 
on the GABAA receptor and can induce mood changes in women. These changes become 89 
more apparent during the premenstrual phase, when the levels of Pg and ALLO are the 90 
highest. Studies in our laboratory have shown that the anxiolytic effect of ALLO in female 91 
rats is associated with their hormonal status (Laconi et al. 2001, Laconi & Cabrera 2002, 92 
Laconi et al. 2007). Recently, we studied the effect of central administration of ALLO 93 
doses that mimic the circulating levels during stress and found that ALLO inhibits LH and 94 
the ovulation rate and increases prolactin serum levels. In addition, ALLO inhibits corpus 95 
luteum apoptosis (Laconi et al. 2012) and the loss of ovulation may be due to its effect 96 
over the hypothalamic-pituitary axis.   97 
Pg stimulates luteal cells to secrete more Pg in a paracrine manner, protecting corpora lutea 98 
from cell death (Stocco et al. 2007). The functional and structural luteal development of 99 
luteal cells is controlled by the action of several luteotropic hormones secreted by the 100 
pituitary gland, the endometrium and the placenta, in the case of pregnancy. Among the 101 
best-known luteotropic hormones are PRL and LH (Niswender et al. 2000). ALLO could 102 
also be a candidate to control the previously mentioned process (Laconi et al. 2012). 103 
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Ovarian cysts are an important cause of subfertility in mammals, as well as of the 104 
Polycystic Ovarian Syndrome and the luteinized unruptured follicle (LUF) syndrome in 105 
women (Summaria et al. 1998, Ali 2015). Cysts can be subdivided into follicular and luteal 106 
cysts, which could be different forms of the same disorder. Follicular cysts are dynamic 107 
structures that develop when one or more follicles fail to ovulate (Vanholder 2006). Some 108 
kinds of cysts do not interfere with the estrous or menstrual cycle (Douthwaite & Dobson 109 
2000, Noble et al. 2000) and can appear in the absence of clear clinical signs, such as 110 
LUFs, which are formed from Graafian follicles in the absence of oocyte expulsion. in 111 
women with normal menstrual cycles and animal models (Killick & Elstein 1987, Van de 112 
Lagemaat et al. 2011). During the follicular phase, granulosa cells acquire luteinization 113 
potential, which is suppressed until ovulation (William & Erickson 2012). In the LUFs, the 114 
process of ovulation is dysregulated. Failure of ovulation due to the luteinization of 115 
follicles under the action of LH is one of the main causes of infertility in women (Qublan 116 
et al., 2006; Summaria et al., 1998).  117 
Considering our previous findings, the aim of this work was to determine the effect of a 118 
dose of ALLO (6 µM i.c.v) on the ovarian morphophysiology, Pg and 17β-estradiol serum 119 
and ovarian levels, and 3β-HSD, 3α-HSOR and 20α-HSD enzymatic activities in the ovary 120 
and MBH. 121 
 122 
Materials and Methods 123 
Animals 124 
Adult female Sprague-Dawley rats (60–90 days old; body weight 200–250 g) bred in our 125 
laboratory were used. Animals were housed at room temperature (22±2°C) with a 12 h 126 
light: 12 h darkness photoperiod in an air-conditioned environment. Food and water were 127 
available ad libitum (standard rat chow Cargil, Córdoba, Argentina). Only animals with 128 
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two consecutive 4-5-day cycles were used for the experiment. The stages of the estrous 129 
cycle were determined daily by vaginal cytology. 130 
 131 
Experimental design 132 
In the morning of proestrous, rats were injected i.c.v. with ALLO (6 µM, 1 µL injection 133 
volume, for 60 sec). Control animals were injected with KREBS solution (as vehicle) 134 
containing propylene glycol at concentrations equivalent to those used in the experimental 135 
groups. The chosen dose of ALLO mimics the serum levels during stress in rats (Purdy et 136 
al. 1991), and is the same dose used in our previous reports (Laconi et al. 2001, 2002, 137 
2012; Giuliani et al. 2013; Pelegrina et al. 2015). Six rats per group were used in each 138 
experiment, which was performed only once. In the morning of estrous (09.00h), vaginal 139 
smears were analyzed. Then, the rats were sacrificed by decapitation. The brains were 140 
rapidly removed and cooled on ice and the MBH explants dissected out. The anterior 141 
border of each block of tissue was made by a coronal cut just anterior to the entry point of 142 
the optic chiasm and the posterior border by a coronal cut just behind the pituitary stalk. 143 
The lateral limits were the hypothalamic fissures and the in-depth limit was the sub-144 
thalamic sulcus. The MBH of each animal was labelled for subsequent measurement of 145 
enzymatic activity. 146 
Serum samples were collected after blood centrifugation and stored at - 30°C until used for 147 
radioimmunoassay (RIA). The ovaries were removed and cleaned free of fat, and oocytes 148 
were collected by the puncture of the ampulla and counted under a light microscope. The 149 
right ovary was frozen to measure Pg and enzymatic activity, whereas the left ovary was 150 
fixed in Bouin solution (Biopur Diagnostics) for subsequent microscopic analysis. All 151 
protocols were previously approved by the Experimental Animal Committee of the 152 
Universidad Nacional de Cuyo, Argentina (CICUAL N° 141021), and conducted according 153 
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to the National Institutes of Health Guide for the Care and Use of Laboratory Animals of 154 
the National Research Council (National Academies, U.S.A., 8th Edition, 2011). 155 
 156 
Drugs 157 
Allopregnanolone (ALLO)[3α-hydroxy-5α-pregnan-20-one] (Sigma Chemical Co., St. 158 
Louis, MO, USA), Penicillin G Benzathine (Richet, Argentina), Ketamine HCL (Holliday -159 
Scott S.A, Buenos Aires Argentina) and Xylazine (Koning Laboratories, Buenos Aires, 160 
Argentina) were used for experimental and surgical procedures. Dihydroprogesterone [5α-161 
Pregnan-3, 20-dione] (Sigma Aldrich, Argentina), Pregnenolone [3β-hydroxy-5-pregnen-162 
20-one] (Sigma Aldrich, Argentina), NAD+ [β-Nicotinamide adenine dinucleotide hydrate] 163 
and NADPH [β-Nicotinamide adenine dinucleotide phosphate] (all from Sigma Aldrich, 164 
Argentina) were used for enzymatic activity determination. ALLO was prepared as 165 
described in our previous papers (Laconi et al. 2001, 2012). Stocks of ALLO were initially 166 
dissolved in propylene glycol to a concentration of 0.6 mM. The dose of ALLO used in the 167 
experiment (6 µM) was obtained by dilutions in Krebs Ringer Bicarbonate glucose 168 
(KRBG) buffer at pH 7.4, to make negligible the final amount of propylene glycol. Control 169 
animals were injected with KRBG buffer at pH 7.4 as vehicle. KRBG preparation 170 
contained propylene glycol in a concentration equivalent to that used in the experimental 171 
groups. 172 
 173 
Determination of the estrous cycle and the ovulation rate 174 
The estrous cycle stage was determined daily (07:00-09:00 am) using vaginal smears 175 
observed with a light microscope. The ovulation rate was determined on the morning of 176 
estrous after the rats were sacrificed to confirm our previous results (Laconi et al., 2012). 177 
After sacrifice, the ovary was placed on a petri dish, moistened slightly and the ampulla 178 
gently punctured. Then, oocytes were removed and counted under a light microscope. 179 
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 180 
Surgical procedures 181 
A stainless-steel cannula was stereotaxically inserted into the right lateral ventricle in rats 182 
anesthetized with an intraperitoneal injection of Ketamine HCL (80 mg /kg) and xylazine 183 
(4 mg/kg). A stainless-steel needle was placed into the guide cannula and connected by a 184 
silicone catheter to a Hamilton microliter syringe. After inoculation, the injection cannula 185 
was maintained for an additional minute to avoid reflux. The following coordinates from 186 
bregma were used, in accordance with Paxinos and Watson’s Atlas (2009), AP: 0.4 mm, L: 187 
-1.5 mm and DV: - 4 mm. At the end of the surgery, the cannula was sealed with a 188 
stainless-steel wire to protect it from obstruction. To prevent infections, each animal 189 
received a subcutaneous injection of 0.2 mL of Penicillin G Benzathine (1,200,000 UI; 1UI 190 
= 0.6 µg; 72 mg/rat). After surgery, animals were housed singly in Plexiglas cages and 191 
maintained undisturbed for a week for recovery. At the end of the experiments, the location 192 
of the guide cannula into the lateral ventricle was confirmed by the injection of blue ink. 193 
Only animals with confirmed microinjection into the right lateral ventricle were included 194 
in the study. 195 
On the morning of proestrous (09:00 h), the experimental group (n= 6 rats) received a 196 
single i.c.v. injection of ALLO (6 µM), and the vehicle group received an i.c.v. injection of 197 
KREBS solution. The total volume of ALLO or vehicle injected was 1 µL for 60 seconds. 198 
 199 
Ovarian morphology 200 
The left ovaries from both experimental groups were removed and immediately fixed in 201 
Bouin solution (Biopur) for 12 hours, dehydrated in ethanol series, cleared in xylene and 202 
embedded in paraffin. Histological sections were made for staining with hematoxylin-eosin 203 
(Merk). Ovaries were cut in serial sections at 5 µm on a rotary microtome, mounted on 204 
slides at 50-µm intervals to prevent counting the same structure twice and examined under 205 
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a light microscope (Zeiss, Germany). From each ovary, the number of secondary (SF), 206 
tertiary (TF), Graafian (GF) and atretic (AtF) follicles as well as corpora lutea (CL), and 207 
cysts (C), including LUFs, were examined under a light microscope (Zeiss Germany). The 208 
follicles were classified in accordance with Williams & Erickson, 2012: SF have multiple 209 
layers of granulosa cells around the oocyte and a theca layer; TF contain a small cavity or 210 
“antrum” field with follicular fluid; in GF, the cavity occupies most of the total follicular 211 
volume and the cumulus appears; AtF were those with more than 10 pycnotic nuclei per 212 
follicle, which also had a degenerate oocyte and precocious antrum formation, or both 213 
(Banka & Erickson 1985, Sadrkhanloo et al. 1987). The CL of each individual were 214 
counted and classified in new and old (previous cycle) according to Westwood (2008), as 215 
follows: New CL: easily found during estrous. They are generally small, but defined, with 216 
basophilic cell cytoplasm, central fluid-filled cavity and no fibrous tissue. (Fig 1, C); Old 217 
CL: might be found throughout the whole cycle. They can present more cytoplasmic 218 
vacuoles indicative of active steroidogenesis, and fibrous tissue proliferation in the central 219 
cavity (Fig 1, D). 220 
Follicular cysts were defined as follicles with or without oocytes that contain a large antral 221 
cavity and a thin granulosa layer. LUFs were defined as structures with an oocyte 222 
surrounded by luteal and granulosa cells, with neo-vascularization (Wang et al. 2008, 223 
Fernandois et al. 2012). The number of these different ovarian structures was determined 224 
in six ovarian sections from each ovary (n=6 ovaries/group) and expressed as Mean ± 225 
S.E.M. The mean diameter of TF, GF and CL was recorded using Image J software. 226 
 227 
Radioimmunoassay for progesterone and estradiol determination in serum and 228 
ovarian tissue 229 
Trunk blood was collected and centrifuged at 3000 rpm for 15 min (Beckman TJ-6RS). 230 
The serum obtained was kept frozen (-30°C) until hormone assays were run. RIA was 231 
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performed using a commercially obtained kit (New England Nuclear Products, Boston, 232 
MA, USA), and used to measure progesterone concentrations in serum and ovaries. In both 233 
cases, Pg was extracted according to Sanchez-Criado et al. (1992). The sensitivity of the 234 
assay was 0.02 ng/mL, and inter- and intra-assay coefficients of variation were 5% and 235 
6%, respectively, for serum measures. 17β-estradiol (E2) concentration in serum was 236 
determined by RIA using a commercial kit (Radim, Pomezia, Italy) based on competition 237 
between antigens labeled with iodine 125 (radioactive conjugate) and non-labeled antigens 238 
(calibrator sample) for specific binding sites in antiserum-coated tubes. After incubation, 239 
all unbound material was removed and radioactivity measured. Uncoated tubes were 240 
prepared for measurements of total activity (T) and non-specific binding (NSB). Tubes 241 
coated with rabbit antibody against E2 were prepared for measurements in the zero 242 
calibrator (Bo), calibrators 1 to 6, control serum, and samples as follows. First, 100 µL of 243 
Bo was added to the NSB tube, and 100 µL of each additional calibrator as well as the 244 
control serum and samples was pipetted into the corresponding tube. Next, 500 µL of the 245 
radioactive conjugate was pipetted into all the tubes, whose contents were then mixed by 246 
vortex. After incubation for 3 h at 37°C, the contents were carefully aspirated by pump 247 
from all tubes except the uncoated T tube. The radioactivity in the tubes was measured 248 
with a γ-counter. The sensitivity of the assay was 2 pg. The intra-assay coefficient of 249 
variation (CV) was 3%. In the case of the ovarian Pg measures, the concentration was 250 
expressed as ng/mg ovary/mL, and assay sensitivity was less than 5 ng Pg/mL. The inter- 251 
and intra-assay CVs were less than 10.0%. For the sake of comparison, some previously 252 
published data regarding Pg serum levels are shown together with Pg ovarian levels.  253 
 254 
Spectrophotometric analysis of enzymatic activity (ovary and MBH) 255 
The right ovary from each animal was used both for Pg determination by RIA (see 256 
previous paragraph) and for enzymatic activity determination. First, the ovaries were 257 
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homogenized in buffer TRIS-HCL, and then an aliquot was taken for determination of 258 
enzyme activities. The remaining aliquot was used for RIA determination. The activities of 259 
3β-HSD, 3α-HSOR and 20α-HSD were measured as described by Kawano et al. (1988) 260 
and Giuliani et al. (2013), with slight modifications (Tellería & Deis, 1994). The method of 261 
Lowry et al. (1951) was used for protein determination using bovine serum albumin (BSA) 262 
as standard. The ovaries and MBH were homogenized in 0.7 mL of 0.1 M Tris-HCl, 1 mM 263 
EDTA buffer (pH 8) at 0° C with a glass homogenizer. The homogenates were centrifuged 264 
at 30000 rpm for 60 min, using a Beckman L T40.2 ultracentrifuge. The supernatants were 265 
used for determine 20α-HSD activity. The precipitates were re-homogenized with 0.25 M 266 
sucrose and then centrifuged at 3000 rpm for 5 min. The supernatants obtained were used 267 
as the enzyme solution to determine 3β-HSD activity. Then, to start the assays, the 268 
substrate for the reaction of 3α-HSOR, pregnenolone, was added to the reaction mix. The 269 
latter contained Glycine-NaOH (pH=9.4), BSA, NAD+ and a fraction of the enzyme 270 
solution. The enzymatic activities were assayed spectrophotometrically using a Zeltec 271 
spectrophometer. The assay of each enzyme measured the reduction of NAD+ or the 272 
oxidation rate of NADPH at 340 nm respectively (Kawano et al. 1988; Takahashi et al. 273 
1995; Escudero et al. 2012) as an increase in absorbance in 1 min at 37°C. A fraction of the 274 
enzymatic solution was reserved for protein quantification. The values of enzymatic 275 
activity were expressed as mU/mg protein/min.  276 
 277 
Data analysis 278 
Data were expressed as the mean ± SEM. Statistical analysis was performed using the 279 
unpaired Student`s t test. Values of p<0.05 were considered significant. Data were 280 
statistically analyzed using Prism v 5.0. 281 
  282
Results  283 
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Estrous cycle and ovulation 284 
ALLO administration at proestrous caused a significant decrease in the ovulation rate. The 285 
percentage of inhibition was of 75%, whereas the administration of vehicle had no effect 286 
(data not shown). Interestingly, the estrous cycle was not modified in any of the 287 
experimental groups.  288 
 289 
Ovarian morphology 290 
The mean numbers of follicles and CL in the ALLO-treated and control groups are shown 291 
in Table 1. In the ALLO-treated group, the number of SF and GF was lower than in the 292 
control group (p<0.05 and p<0.01, respectively). In contrast, the number of follicular cysts 293 
and LUFs was increased in the ALLO-treated group (p<0.001). No significant differences 294 
were found in the number of TF and CL between both groups. ALLO increased the number 295 
of old CL and decreased the number of new CL, compared to the untreated group. There 296 
were no significant differences between the diameters of TF, GF and CL between the 297 
ALLO-treated and control animals (Table 1). Figure 1 (upper panel) shows representative 298 
photomicrographs of a whole control ovary (A) and a whole ALLO-treated ovary (B), 299 
which display a LUF with retained oocyte, a large antrum and intense vascularization. 300 
Figure 1 (lower panel) shows photomicrographs of new (Fig 1, C) and old corpora lutea 301 
(Fig 1, D).  302 
 303 
Progesterone and estrogen levels 304 
ALLO administration induced a significant increase in Pg serum levels with respect to the 305 
control group (p<0.001, Fig 2, A). However, the opposite results were found in the ovaries, 306 
where Pg levels were lower than those of the control group (p<0.001, Fig. 2B). The 307 
administration of ALLO did not alter serum or ovarian estradiol levels when compared 308 
with the control group (Fig 2, C and D)  309 
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 3β-HSD, 3α-HSOR and 20α-HSD enzymatic activity 311 
The 3β-HSD activity in MBH of ALLO-treated animals was significantly higher than that 312 
of the control group (p<0.05, Fig. 3A). In the ovaries, the opposite results (p<0.05, Fig. 313 
3B) were found: 3β-HSD was lower in the ALLO-treated groups than in the control group. 314 
The same changes in the enzymatic activity of 3α-HSOR were observed in both MBH and 315 
ovarian samples (p<0.05, Fig. 3C and D). Finally, ALLO administration induced a 316 
decrease in the activity of 20α-HSD in the MBH and an increase in the activity of 20α-317 
HSD in the ovary (p<0.05, Fig. 3 E and F).  318 
 319 
Discussion 320 
Ovulation is one of the main female reproductive events. It is a consequence of sequential 321 
steps that begin early in life with the formation of primordial follicles and then, during the 322 
fertile period with cyclic follicular development. This process is controlled by the 323 
hypothalamic-pituitary-ovarian axis, which is accompanied by an increased sympathetic 324 
tone. ALLO plays a determinant role in the regulation of the reproductive function in 325 
female rats. We have previously shown that ALLO modifies the ovulation pattern, acting 326 
at the level of the dopaminergic, GABAergic and glutamatergic systems (Laconi et al. 327 
2001, 2012, Laconi & Cabrera 2002, Giuliani et al. 2013). Based on these previous 328 
findings, this study was designed to analyze the putative effect of a single dose of ALLO 329 
i.c.v. over morphometric parameters and ovarian and hypothalamic steroidogenesis. 330 
We confirmed that the i.c.v administration of ALLO inhibited ovulation, a mechanism 331 
controlled primarily by the pituitary LH. ALLO administration did not alter the estrous 332 
cycle. These results are in agreement with those of Genazzani et al. (1995), who had 333 
already found that after the administration of anti-ALLO serum, the anovulatory effect of 334 
the neurosteroid was reversed. 335 
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In the present study, we observed that ALLO affects the process of follicle maturation. In 336 
the ALLO-treated group, the number of SF and GF was significantly lower than in the 337 
control group whereas their diameter was not affected. On the other hand, ALLO increased 338 
the number of AtF. As shown in one of our previous works (Laconi et al. 2012), ALLO 339 
interferes with gonadotropin release. At a concentration in the order of µM, ALLO is able 340 
to decrease LH serum levels, whereas at a concentration in the order of nM, it is able to 341 
increase GnRH levels (Giuliani et al. 2011). These findings support the idea that ALLO 342 
alters gonadal steroidogenesis and thus disrupts follicular development. ALLO may also 343 
alter the balance between survival and death factors in follicular cells, leading to the atresia 344 
of developing follicles.  345 
The ovulatory process, which involves the breakdown of the theca layers, which in turn 346 
allows the release of the oocyte, is dependent on Pg and the regulation of proteolytic 347 
activity. In addition, this process is dependent on the pre-ovulatory LH surge that induces 348 
the secretion of follicular Pg (Gaytán et al. 2002). Our findings suggest that ALLO inhibits 349 
ovulation by decreasing the ovarian levels of Pg, an effect that seems to be mediated by the 350 
inhibition of 3β-HSD activity and by an increase in 20α-HSD activity. 351 
Previously, we found that ALLO affects luteal regression through inhibition of apoptosis 352 
(Laconi et al. 2012). In this study, we observed that in animals injected with ALLO the 353 
mean number of CL and their diameters had no differences respect to the control group. 354 
Although the difference of the total number of CL remained statistically not significant, 355 
there was a difference in the number of new and old CL between the ALLO-treated group 356 
and the control group. The decrease in the number of new CL could be a consequence of 357 
the inhibition of ovulation or of the increase in the number of atretic and cystic follicles. 358 
The increase in the number of old CL could be associated with a decrease in the apoptotic 359 
process in the CL (Laconi et al. 2012). 360 
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The increase in 20α-HSD activity and the decrease in 3β-HSD activity observed in the 361 
present study, together with the decline in the number of new CL, would be the cause for 362 
the decrease in ovarian Pg levels. Luteal regression initiates with a decline in the 363 
biosynthesis of Pg (Clementi et al. 2004), which is then followed by the activation of the 364 
catabolism of Pg by 20α-HSD, an established marker for luteal regression.  365 
Moreover, as is well known, follicle maturation is a process regulated by gonadotropins, 366 
hormones and local growth factors (Fortune et al. 2004). Follicular growth and oocyte 367 
maturation are dependent primarily on FSH and LH (Canipari et al. 2012). Mattheij & 368 
Swarts (1995) linked a deficiency in the secretion of LH in the period prior to ovulation 369 
with the formation of LUFs. Therefore, the central effect of ALLO over the reproductive 370 
function may be due to decreased LH levels, which affect folliculogenesis and thus inhibit 371 
ovulation. This process would be involved in the formation of ovarian cysts and, in 372 
particular, LUFs. This is in agreement with that found by Vanholder et al. (2006), who 373 
mentioned that low LH levels lead to the formation of cystic structures, which do not 374 
interfere with the normal ovarian cycle in cows. Women with LUFs have a normal 375 
menstrual cycle without ovulation (Summaria et al. 1998). The same situation occurred in 376 
our experimental model, where the rats presented a normal four-five-day cycle, with 377 
regular vaginal smears, with a significant reduction of the ovulation, even though follicular 378 
cysts and LUF were increased.  379 
In our model, ALLO probably affects the selection-recruitment of dominant follicles to 380 
ovulate, preventing them to reach the GF state, thus leading to the formation of cystic 381 
structures. This idea reinforces our hypothesis about the importance of this neurosteroid in 382 
the reproductive function, in particular in the functionality of ovarian structures.  383 
On the other hand, we found that ALLO increased serum Pg levels and decreased ovarian 384 
Pg levels, but did not affect serum or ovarian estrogen levels. All these results suggest that 385 
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ALLO acts both at central (CNS) and peripheral levels (adrenal and ovarian levels) 386 
(Micevych and Sinchak, 2011).  387 
In this study, we measured the ovarian and MBH enzymatic activities of 3β-HSD, 3α-388 
HSOR and 20α-HSD, which mediate the synthesis and metabolism of Pg and ALLO 389 
respectively. We found that the activities of both 3β-HSD and 3α-HSOR had the same 390 
profile. They were increased at MBH and decreased in ovarian tissue, suggesting a 391 
relationship between the central and ovarian effect of ALLO. However, 20α-HSD activity 392 
followed the opposite profile: in the MBH, it might regulate the availability of locally 393 
produced Pg from Pg receptors, and thus control the influence of Pg over neuronal activity; 394 
in the ovary, it plays a relevant role in the induction of luteolysis (Stocco et al., 2007; 395 
Pelletier et al., 2004). 396 
De Rensis & Scaramuzzi (2003) have shown the effect of heat stress over female fertility. 397 
The decrease in fertility is associated with an increased body temperature that alters 398 
ovarian function and oocyte health (Hansen 2007). Wolfenson et al. (1997, 2000) have 399 
reported that stress can alter follicular development, lead to the formation of suboptimal 400 
CL and low Pg concentration, and reduce steroid hormone production. Similarly, we 401 
reported that a concentration of ALLO that mimics stress levels also has a deleterious 402 
effect on GF, leading to the formation of cystic and luteinized structures. ALLO, at stress 403 
level concentrations, may generate a cascade of effects from the hypothalamus and 404 
pituitary gland to the ovary, impairing the whole equation of female fertility. It alters luteal 405 
function and follicular development, reduces ovarian Pg concentration, decreases the 406 
enzymatic activities of 3β-HSD and 3α-HSOR, and increases 20α-HSD activity.  407 
In conclusion, ALLO alters key enzymes of its own synthesis and generates a special 408 
microenvironment, causing alterations in steroidogenesis, perhaps responsible for the 409 
morphological changes in follicles and the development of cystic structures, reinforcing the 410 
idea that ALLO is a potent modulator of female reproductive function.  411 
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More studies are needed to ascertain if ALLO actions could affect the ovarian tissue 412 
directly. We are currently studying the effect of an ALLO intra-bursal injection and 413 
determining ALLO serum levels.  414 
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Figure 1: Top panel: Light micrographs of whole ovaries from rats after treatment with vehicle 
(A) or ALLO (B). Inset: Luteinized unruptured follicle (LUF) containing an oocyte (O). A 
secondary follicle (SF), a tertiary follicle (TF), corpora lutea (CL), an atretic follicle (AtF), and a 
cyst (C) are also shown. Bottom panel: Representative micrographs of a new corpus luteum (C) 
with basophilic cells (BC) and a fluid filled cavity (FFC); and an old corpus luteum (D) with 
central fibrous tissue formation (FT) and luteinized cells (LC). Scale bars in A and B represent 
200 µm, in C and D 100 µm. 
 
Figure 2: Radioimmunoassay of progesterone (top panel) and estrogen (bottom panel) serum 
levels (ng/mL) (A-C) and ovarian tissue levels (ng/mg) (B-D). Allopregnanolone (ALLO). Bars 
represent the mean ± S.E.M. (n= 6; ***p<0.001).  
 
Figure 3: Spectrophotometric analysis of ALLO effect over 3β-HSD (A-B), 3α-HSOR (C-D) and 
20 α-HSD (E-F) enzymatic activities in the Medial Basal Hypothalamus (MBH left panel) and in 
the ovary (right panel) of estrous rats. Bars represent the mean ± S.E.M. (n= 6; *p<0.05, 
**p<0.01 and ***p<0.001).  
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Values expressed as Mean ± S.E.M., ns=not significant; LUF: Luteinized unruptured follicles, CL: corpora lutea. 
Structures 
 
Control (n=6)   ALLO (n=6)   p value 
Secondary follicles (n) 3.94 ± 0.56   2.77 ± 0.33   p < 0.05 
Tertiary follicles (n) 7.5 ± 0.96  6.2 ± 0.95  ns 
Graafian follicles (n) 5.1 ± 0.45  3 ± 0.66  p < 0.01 
Atretic follicles (n) 2.75 ± 1.1  4.77 ± 0.9  p < 0.001 
Corpora lutea (n) 7.65 ± 2.20  6.35 ± 1.1  ns 
New CL (n) 3.55 ± 1.16  1.60 ± 0.85  p < 0.01 
Old CL (n) 3.25 ± 2  5.76 ± 2.26  p < 0.001 
Cysts and LUFs (n) 2 ± 0.55   6 ± 1.33   p< 0.001 
Diameter of tertiary follicles (µm) 428.87 ± 102.49   432.53 ± 104.28   ns 
Diameter of Graafian follicles (µm) 650.85 ± 97.62  603.62 ± 65.12  ns 
Diameter of corpora lutea (µm) 758 ± 65.01   836.3 ± 82.3   ns 




Figure 1: Top panel: Light micrographs of whole ovaries from rats after treatment with vehicle (A) or ALLO 
(B). Inset: Luteinized unruptured follicle (LUF) containing an oocyte (O). A secondary follicle (SF), a tertiary 
follicle (TF), corpora lutea (CL), an atretic follicle (AtF), and a cyst (C) are also shown. Bottom panel: 
Representative micrographs of a new corpus luteum (C) with basophilic cells (BC) and a fluid filled cavity 
(FFC); and an old corpus luteum (D) with central fibrous tissue formation (FT) and luteinized cells (LC). 
Scale bars in A and B represent 200 µm, in C and D 100 µm.  
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Caption : Figure 2: Radioimmunoassay of progesterone (top panel) and estrogen (bottom panel) serum 
levels (ng/mL) (A-C) and ovarian tissue levels (ng/mg) (B-D). Allopregnanolone (ALLO). Bars represent the 
mean ± S.E.M. (n= 6; ***p<0.001).  
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Caption : Figure 3: Spectrophotometric analysis of ALLO effect over 3β-HSD (A-B), 3α-HSOR (C-D) and 20 
α-HSD (E-F) enzymatic activities in the Medial Basal Hypothalamus (MBH left panel) and in the ovary (right 
panel) of estrous rats. Bars represent the mean ± S.E.M. (n= 6; *p<0.05, **p<0.01 and ***p<0.001).  
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